Tenaya Therapeutics, Inc.TNYANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-91.53M
↓ 15% below average
Average (5y)
$-79.68M
Historical baseline
Range
High:$-27.02M
Low:$-125.05M
CAGR
+27.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-91.53M | +11.4% |
| 2023 | $-103.31M | +17.4% |
| 2022 | $-125.05M | -45.5% |
| 2021 | $-85.93M | -90.1% |
| 2020 | $-45.21M | -67.3% |
| 2019 | $-27.02M | - |